ANDREA ELLIS: Open Payments
NPI 1770070898 · SANFORD, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$412 in 19 payments from 7 companies in 2025. Trend: 2023 $186 · 2024 $0 · 2025 $412
Food & beverage: $412
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 5 | $96 |
| Teva Pharmaceuticals USA, Inc. | 4 | $85 |
| Luye Pharma (USA) Ltd. | 3 | $65 |
| Alkermes, Inc. | 2 | $54 |
| Axsome Therapeutics, Inc. | 2 | $48 |
| E.R. Squibb & Sons, L.L.C. | 2 | $34 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $31 |
Products named: ABILIFY MAINTENA, ERZOFRI EXTENDED-RELEASE, UZEDY, Auvelity, COBENFY, REJOYN, ARISTADA, LYBALVI.
Industry payments across FL — which companies pay providers there.
